178 related articles for article (PubMed ID: 21272923)
21. Parthenolide has limited effects on nuclear factor-kappa beta increases and worsens survival in lipopolysaccharide-challenged C57BL/6J mice.
Li X; Cui X; Li Y; Fitz Y; Hsu L; Eichacker PQ
Cytokine; 2006 Mar; 33(6):299-308. PubMed ID: 16720096
[TBL] [Abstract][Full Text] [Related]
22. 5-Hydroxytryptamine-inhibiting property of Feverfew: role of parthenolide content.
Mittra S; Datta A; Singh SK; Singh A
Acta Pharmacol Sin; 2000 Dec; 21(12):1106-14. PubMed ID: 11603284
[TBL] [Abstract][Full Text] [Related]
23. Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide.
Patel NM; Nozaki S; Shortle NH; Bhat-Nakshatri P; Newton TR; Rice S; Gelfanov V; Boswell SH; Goulet RJ; Sledge GW; Nakshatri H
Oncogene; 2000 Aug; 19(36):4159-69. PubMed ID: 10962577
[TBL] [Abstract][Full Text] [Related]
24. Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF-kappaB.
Oka D; Nishimura K; Shiba M; Nakai Y; Arai Y; Nakayama M; Takayama H; Inoue H; Okuyama A; Nonomura N
Int J Cancer; 2007 Jun; 120(12):2576-81. PubMed ID: 17290398
[TBL] [Abstract][Full Text] [Related]
25. Quantification of parthenolide in Tanacetum species by LC-UV/LC-MS and microscopic comparison of Mexican/US feverfew samples.
Avula B; Navarrete A; Joshi VC; Khan IA
Pharmazie; 2006 Jul; 61(7):590-4. PubMed ID: 16889065
[TBL] [Abstract][Full Text] [Related]
26. Biosynthesis and localization of parthenolide in glandular trichomes of feverfew (Tanacetum parthenium L. Schulz Bip.).
Majdi M; Liu Q; Karimzadeh G; Malboobi MA; Beekwilder J; Cankar K; Vos Rd; Todorović S; Simonović A; Bouwmeester H
Phytochemistry; 2011 Oct; 72(14-15):1739-50. PubMed ID: 21620424
[TBL] [Abstract][Full Text] [Related]
27. Platelets and megakaryocytes contain functional nuclear factor-kappaB.
Spinelli SL; Casey AE; Pollock SJ; Gertz JM; McMillan DH; Narasipura SD; Mody NA; King MR; Maggirwar SB; Francis CW; Taubman MB; Blumberg N; Phipps RP
Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):591-8. PubMed ID: 20042710
[TBL] [Abstract][Full Text] [Related]
28. Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies.
Jorge J; Neves J; Alves R; Geraldes C; Gonçalves AC; Sarmento-Ribeiro AB
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298119
[TBL] [Abstract][Full Text] [Related]
29. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J
J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591
[TBL] [Abstract][Full Text] [Related]
30. Megakaryocytes and platelets express nicotinic acetylcholine receptors but nicotine does not affect megakaryopoiesis or platelet function.
Schedel A; Kaiser K; Uhlig S; Lorenz F; Sarin A; Starigk J; Hassmann D; Bieback K; Bugert P
Platelets; 2016; 27(1):43-50. PubMed ID: 25902378
[TBL] [Abstract][Full Text] [Related]
31. Regulation of Human Platelet Activation and Prevention of Arterial Thrombosis in Mice by Auraptene through Inhibition of NF-κB Pathway.
Hsia CW; Wu MP; Shen MY; Hsia CH; Chung CL; Sheu JR
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32646046
[TBL] [Abstract][Full Text] [Related]
32. Parthenolide content and bioactivity of feverfew (Tanacetum parthenium (L.) Schultz-Bip.). Estimation of commercial and authenticated feverfew products.
Heptinstall S; Awang DV; Dawson BA; Kindack D; Knight DW; May J
J Pharm Pharmacol; 1992 May; 44(5):391-5. PubMed ID: 1359053
[TBL] [Abstract][Full Text] [Related]
33. Parthenolide, an inhibitor of the nuclear factor-kappaB pathway, ameliorates cardiovascular derangement and outcome in endotoxic shock in rodents.
Sheehan M; Wong HR; Hake PW; Malhotra V; O'Connor M; Zingarelli B
Mol Pharmacol; 2002 May; 61(5):953-63. PubMed ID: 11961112
[TBL] [Abstract][Full Text] [Related]
34. Redox state of dipyridamole is a critical determinant for its beneficial antioxidant and antiinflammatory effects.
Chakrabarti S; Blair P; Wu C; Freedman JE
J Cardiovasc Pharmacol; 2007 Oct; 50(4):449-57. PubMed ID: 18049314
[TBL] [Abstract][Full Text] [Related]
35. Parthenolide, a feverfew-derived phytochemical, ameliorates obesity and obesity-induced inflammatory responses via the Nrf2/Keap1 pathway.
Kim CY; Kang B; Suh HJ; Choi HS
Pharmacol Res; 2019 Jul; 145():104259. PubMed ID: 31078744
[TBL] [Abstract][Full Text] [Related]
36. Parthenolide is the component of tanacetum parthenium that inhibits nitroglycerin-induced Fos activation: studies in an animal model of migraine.
Tassorelli C; Greco R; Morazzoni P; Riva A; Sandrini G; Nappi G
Cephalalgia; 2005 Aug; 25(8):612-21. PubMed ID: 16033387
[TBL] [Abstract][Full Text] [Related]
37. Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase.
Nakshatri H; Rice SE; Bhat-Nakshatri P
Oncogene; 2004 Sep; 23(44):7330-44. PubMed ID: 15286701
[TBL] [Abstract][Full Text] [Related]
38. Intra-specific variability of feverfew: correlations between parthenolide, morphological traits and seed origin.
Cutlan AR; Bonilla LE; Simon JE; Erwin JE
Planta Med; 2000 Oct; 66(7):612-7. PubMed ID: 11105564
[TBL] [Abstract][Full Text] [Related]
39. Extracts of feverfew inhibit granule secretion in blood platelets and polymorphonuclear leucocytes.
Heptinstall S; White A; Williamson L; Mitchell JR
Lancet; 1985 May; 1(8437):1071-4. PubMed ID: 2860288
[TBL] [Abstract][Full Text] [Related]
40. Parthenolide and costunolide reduce microtentacles and tumor cell attachment by selectively targeting detyrosinated tubulin independent from NF-κB inhibition.
Whipple RA; Vitolo MI; Boggs AE; Charpentier MS; Thompson K; Martin SS
Breast Cancer Res; 2013; 15(5):R83. PubMed ID: 24028602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
